Spotlight Growth
No Result
View All Result
Friday, February 3, 2023
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener
No Result
View All Result
No Result
View All Result
Home Opinion

3 Undervalued OTC Warrants To Consider

by admin
May 20, 2018
in Opinion, Technology
0
Three OTC Warrants Undervalued To Consider Opinion

Three OTC Warrants Undervalued To Consider Opinion

If you’re unfamiliar with warrants, they have many of the characteristics of a call option. More specifically they trade like LEAPs, or long-term options. Each warrant has a strike price and an expiration date like an option. But unlike an option these terms are not standardized. The company sets the terms when issuing the warrant.

Let’s take a look at three OTC warrants that may be undervalued right now.

Interspace Diagnostics Group, Inc. (OTC Pink: IDGGW):

Interpace Diagnostics (OTC Pink: IDGX) warrants trade on the OTC market under the symbol “IDGGW”. The warrants are convertible into Interpace common stock at a strike price of $1.25 and most recently traded at $.15. The expiration date for the warrants is not until June 20, 2022.

With Interpace trading recently at $.96 it is unusual for a warrant with over four years before expiration to trade at such a low premium. Though thinly traded, even as recently as late 2017 the warrant traded at over $.40.

Interpace is in the business of providing molecular diagnostic tests. These tests help avoid unnecessary surgeries and allow a physician to deliver a better level of care.

Interpace announced last month that their tests will now be available to one of the largest integrated health care systems in the U.S. With continued news like this even a small move in the common stock could cause a large move in the Interpace warrant.

Tetra Technologies, Inc. (OTC Grey: TTTNW):

Another OTC warrant which may be a value in hindsight is the Tetra Technologies, Inc. (NYSE: TTI) warrant trading under the symbol “TTTNW”. The Tetra warrants are exercisable at $5.75 and expire December 14, 2021. They last traded at $1.15.

If oil continues to rise, Tetra warrants will be a major value play. Tetra performs a variety of support services for the oil and natural gas industries. The stock has risen along with the oil rally, and appears to have recently broken through resistance at $5.50.

The warrants traded to $1.80 as recently as February 2017 and could easily retrace back to that level as the common rises.

Sunworks, Inc. (OTC Pink: SUNWW):

Finally, let’s take a look at the warrants of Sunworks, Inc. (NASDAQ: SUNW).  The OTC warrants trade under the symbol “SUNWW”, and most recently traded at $.13. The warrants are exercisable at $4.15, and expire on March 9, 2020.

Admittedly these are a little more of a longshot than our other two warrants. But, the company traded in the $4 range a few years ago.

Sunworks just lined-up a $3.8 million loan to recapitalize. And, $750,000 of that loan came from two current officers of the company. As the founder of the company is retiring, these executives are willing to put their personal money into the company.

The Sunwork derivatives don’t need the stock to return to $4 to see a bump. The low price of the warrants, combined with even a small move in the stock, could lead to a nice return in the warrants.

Each of these three OTC warrants could see a bump in short order. They each offer unique value propositions in their own right.

Disclaimer: The author and/or Spotlight Growth has no positions in any of the stocks mentioned in this article. Nor does either party have any relationship, or any other conflicts of interest, with any of the companies mentioned in this article. This article is meant for research, informational and entertainment purposes only and should not be seen as a recommendation to buy or sell any securities listed. Please visit a licensed investment representative to determine if any investment is right for you.

Article By: Steven Adams

Tags: biopharmaceuticalsbiotechcommon stockderivativesemerging growthenergyinvestmentmanufacturingmedicalMergermicrocap stocksNASDAQnewsNYSEoilotc marketspharmaceuticalspublic companysalesservicessmall cap companiessmall cap stockssmall capsSpotlight GrowthSpotlight Growth Stocksstock marketstockstechTechnologytechnology stockstradetradingtreatmentwarrants
  • Trending
  • Comments
  • Latest
Asure Software NASDAQ ASUR Human Capital Management HCM Industry Spotlight Growth

Asure Software (NASDAQ: ASUR) is Expanding to Meet the Rising Demand for Human Capital Management Software

September 27, 2022
OLB Group NASDAQ OLB Cuentas NASDAQ CUEN Partnership Fintech Spotlight Growth

OLB Group (NASDAQ: OLB) and Cuentas (NASDAQ: CUEN) Team Up to Bring Fintech Solutions to Over 32,000 Bodegas Across the United States

October 6, 2022
Siyata Mobile NASDAQ SYTA SYTAW SD7 VK7 Purchase Orders Spotlight Growth

New Purchase Orders for SD7 Rugged Device, VK7, and Other Accessories Boost Siyata Mobile’s Outlook (NASDAQ: SYTA)

December 14, 2021
Telcoin TEL Crypto Spotlight Growth

Telcoin (TEL) Quietly Leads a Crypto Remittance Revolution

June 15, 2021
Cybersecurity Stocks Coming Into Focus Amid High-Profile Attacks

Cybersecurity Stocks Coming Into Focus Amid High-Profile Attacks

0
Safe-T SFET NASDAQ UN Presentation

Safe-T (NASDAQ: SFET) Has Been Selected to Present at the United Nations’ Office of Information and Communications Technology Event

0
Safe-T Group SFET Q4 FY 2020 Financial Results

Safe-T Group (NASDAQ: SFET) Reports Fourth Quarter and Full Year 2020 Financial Results

0
Safe-T Group NASDAQ SFET FY 2020 Prelim

Safe-T Group Ltd. (NASDAQ: SFET) Estimates Record-High Annual Revenues of Approximately $4.9 Million Representing ~50% Growth YoY 2020

0
Elys Game Technology Corp NASDAQ ELYS Completes Acquisition of Engage IT Services Spotlight Growth

Elys Game Technology Corp (NASDAQ: ELYS) Completes Acquisition of Engage IT Services, a Software Engineering and IT Development Company

February 2, 2023
Tenax Therapeutics NASDAQ TENX US Patent Levosimendan PH-HFpEF Spotlight Growth

Tenax Therapeutics (NASDAQ: TENX) Granted U.S. Patent for IV Levosimendan for Pulmonary Hypertension with Heart Failure and Preserved Ejection Fraction (PH-HFpEF)

February 2, 2023
Versus Systems NASDAQ VS Resolve Debt Partner AI Gamification Consumer Debt Spotlight Growth

Versus Systems (NASDAQ: VS) and Resolve Debt Partner to Integrated Generative AI and Gamification to Customer Payments and Credit Markets

February 1, 2023
Finding the Most Accurate Technical Analysis Indicator Spotlight Growth

Finding the Most Accurate Technical Analysis Indicator

January 31, 2023
ADVERTISEMENT

Recent News

Elys Game Technology Corp NASDAQ ELYS Completes Acquisition of Engage IT Services Spotlight Growth

Elys Game Technology Corp (NASDAQ: ELYS) Completes Acquisition of Engage IT Services, a Software Engineering and IT Development Company

February 2, 2023
Tenax Therapeutics NASDAQ TENX US Patent Levosimendan PH-HFpEF Spotlight Growth

Tenax Therapeutics (NASDAQ: TENX) Granted U.S. Patent for IV Levosimendan for Pulmonary Hypertension with Heart Failure and Preserved Ejection Fraction (PH-HFpEF)

February 2, 2023

Categories

  • Bio/Med/Pharma
  • Cannabis
  • Commodities
  • Consumer Goods
  • Crowdfunding
  • Crypto Cheat Sheets
  • Cryptocurrency
  • Earnings
  • Education
  • Entertainment
  • Financials
  • Market News
  • Opinion
  • Politics
  • Real Estate
  • Split Watch
  • Sponsored
  • Store
  • Technology
  • Uncategorized
  • Venture Capital/Private Equity (VC/PE)

Site Navigation

  • Disclosures
  • Terms Of Service
  • Privacy Policy
  • Contact Us

Copyright © 2017-2022 Spotlight Growth. All Right Reserved. Designed by Cool Cat Interactive.

No Result
View All Result
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener

Copyright © 2017-2022 Spotlight Growth. All Right Reserved. Designed by Cool Cat Interactive.

Newsletter Signup

Subscribe to our weekly newsletter below and never miss the latest small/micro-cap analysis and investment news from Spotlight Growth.

Enter your email address

Thanks, I’m not interested